As Breakthrough Victoria present their third annual report, it is important to reflect on the progress made.
Founded on the belief that good ideas should be developed for the benefit of Victorians, we have now committed capital of more than $350 million across 44 investments, 35 companies (including 5 follow-on investments), one fund, six university platforms and the Jumar Bioincubator.
As BV matures and the company’s portfolio grows, the focus naturally shifts to helping portfolio company’s grow and continue solving globally significant problems, creating industries of the future, improving health and wellbeing, and delivering prosperity and sustainable returns for Victoria over the next decade and beyond.
Part of this growth will see BV continue to support these companies via follow-on investments.
The last financial year saw BV execute five follow-on investments with a total value of more than $35 million.
They included:
Atmo Biosciences:
A Victorian medical technology company that has created a world-first gas-sensing capsule to help diagnose functional gastrointestinal disorders, which research shows affect almost 40 per cent of Australians.
Cadmus:
An online assessment platform designed to enhance the educational experience for both students and educators.
Cyban:
A Victorian company developing a medical device that monitors brain oxygen levels to help prevent people with a brain injury from suffering permanent brain damage or death.
Infleqtion:
A US-based global quantum leader formally known as ColdQuanta.
Seer Medical:
Victorian medical technology group developing neurological monitoring with the potential to boost health outcomes for patients across the world.